褪黑素治疗快速眼动睡眠行为障碍：证据的批判性综述
Melatonin therapy for REM sleep behavior disorder: a critical review of evidence.
作者信息
McGrane Ian R, Leung Jonathan G, St Louis Erik K, Boeve Bradley F
机构信息
Department of Pharmacy, Shodair Children's Hospital, 2755 Colonial Dr, Helena, MT 59601, USA.
Department of Pharmacy, Mayo Clinic College of Medicine, Mayo Clinic, 1216 2nd Street Southwest, Rochester, MN 55902, USA.
出版信息
Sleep Med. 2015 Jan;16(1):19-26. doi: 10.1016/j.sleep.2014.09.011. Epub 2014 Oct 13.
Abstract
Rapid eye movement (REM) sleep behavior disorder (RBD) is a parasomnia associated with dream enactment often involving violent or potentially injurious behaviors during REM sleep that is strongly associated with synucleinopathy neurodegeneration. Clonazepam has long been suggested as the first-line treatment option for RBD. However, evidence supporting melatonin therapy is expanding. Melatonin appears to be beneficial for the management of RBD with reductions in clinical behavioral outcomes and decrease in muscle tonicity during REM sleep. Melatonin also has a favorable safety and tolerability profile over clonazepam with limited potential for drug-drug interactions, an important consideration especially in elderly individuals with RBD receiving polypharmacy. Prospective clinical trials are necessary to establish the evidence basis for melatonin and clonazepam as RBD therapies.
摘要
快速眼动（REM）睡眠行为障碍（RBD）是一种与梦境演绎相关的异态睡眠，通常在快速眼动睡眠期间涉及暴力或潜在伤害行为，与突触核蛋白病神经变性密切相关。长期以来，氯硝西泮一直被建议作为RBD的一线治疗选择。然而，支持褪黑素治疗的证据正在不断增加。褪黑素似乎对RBD的管理有益，可改善临床行为结果，并降低快速眼动睡眠期间的肌肉张力。与氯硝西泮相比，褪黑素还具有良好的安全性和耐受性，药物相互作用的可能性有限，这在接受多种药物治疗的老年RBD患者中是一个重要的考虑因素。有必要进行前瞻性临床试验，以确立褪黑素和氯硝西泮作为RBD治疗方法的证据基础。
相似文献
1
Melatonin therapy for REM sleep behavior disorder: a critical review of evidence.褪黑素治疗快速眼动睡眠行为障碍：证据的批判性综述
Sleep Med. 2015 Jan;16(1):19-26. doi: 10.1016/j.sleep.2014.09.011. Epub 2014 Oct 13.
2
REM sleep behaviour disorder.快速眼动睡眠行为障碍。
Nat Rev Dis Primers. 2018 Aug 30;4(1):19. doi: 10.1038/s41572-018-0016-5.
3
A two-part, double-blind, placebo-controlled trial of exogenous melatonin in REM sleep behaviour disorder.褪黑素治疗 REM 睡眠行为障碍的双盲、安慰剂对照、两部分研究。
J Sleep Res. 2010 Dec;19(4):591-6. doi: 10.1111/j.1365-2869.2010.00848.x.
4
Current Concepts and Controversies in the Management of REM Sleep Behavior Disorder.目前 REM 睡眠行为障碍管理中的新概念和争议。
Neurotherapeutics. 2021 Jan;18(1):107-123. doi: 10.1007/s13311-020-00983-7. Epub 2021 Jan 6.
5
REM Sleep Behavior Disorder in Parkinson's Disease and Other Synucleinopathies.帕金森病及其他α-突触核蛋白病中的快速眼动睡眠行为障碍
Mov Disord. 2017 May;32(5):645-658. doi: 10.1002/mds.27018.
6
Impaired GABA and glycine transmission triggers cardinal features of rapid eye movement sleep behavior disorder in mice.GABA 和甘氨酸递质传递受损会引发小鼠快速眼动睡眠行为障碍的主要特征。
J Neurosci. 2011 May 11;31(19):7111-21. doi: 10.1523/JNEUROSCI.0347-11.2011.
7
Treatment outcomes in REM sleep behavior disorder.快速眼动睡眠行为障碍的治疗结果。
Sleep Med. 2013 Mar;14(3):237-42. doi: 10.1016/j.sleep.2012.09.018. Epub 2013 Jan 23.
8
Melatonin therapy for REM sleep behavior disorder.褪黑素治疗快速眼动睡眠行为障碍。
Psychiatry Clin Neurosci. 2001 Jun;55(3):267-9. doi: 10.1046/j.1440-1819.2001.00854.x.
9
Twenty Years After: Another Case Report of Melatonin Effects on REM Sleep Behavior Disorder, Using Serial Dopamine Transporter Imaging.二十年后：又一例褪黑素对 REM 睡眠行为障碍作用的病例报告，采用连续多巴胺转运体成像。
Neuropsychobiology. 2017;76(2):100-104. doi: 10.1159/000488893. Epub 2018 Jun 1.
10
Melatonin in rapid eye movement sleep behavior disorder: why does it work?褪黑素与快速眼动睡眠行为障碍：它为何起作用？
Sleep Med. 2013 Aug;14(8):705-6. doi: 10.1016/j.sleep.2013.05.004. Epub 2013 Jul 17.
引用本文的文献
1
Lewy Body Dementia.路易体痴呆
Continuum (Minneap Minn). 2024 Dec 1;30(6):1673-1698. doi: 10.1212/CON.0000000000001496.
2
Vascular Pathogenesis in Acute and Long COVID: Current Insights and Therapeutic Outlook.急性和长期新冠病毒感染中的血管发病机制：当前见解与治疗前景
Semin Thromb Hemost. 2025 Apr;51(3):256-271. doi: 10.1055/s-0044-1790603. Epub 2024 Sep 30.
3
Polysomnographic features associated with clonazepam and melatonin treatment in isolated REM sleep behavior disorder: Time for new therapeutic approaches?孤立性 REM 睡眠行为障碍中氯硝西泮和褪黑素治疗相关的多导睡眠图特征：是否需要新的治疗方法？
CNS Neurosci Ther. 2024 Feb;30(2):e14569. doi: 10.1111/cns.14569.
4
The Effect of Melatonin Supplementation on Cancer-Related Fatigue during Chemotherapy Treatment of Breast Cancer Patients: A Double-Blind, Randomized Controlled Study.补充褪黑素对乳腺癌患者化疗期间癌因性疲乏的影响：一项双盲、随机对照研究。
Cancers (Basel). 2024 Feb 16;16(4):802. doi: 10.3390/cancers16040802.
5
Significant potential of melatonin therapy in Parkinson's disease - a meta-analysis of randomized controlled trials.褪黑素疗法在帕金森病中的显著潜力——一项随机对照试验的荟萃分析
Front Neurol. 2023 Oct 10;14:1265789. doi: 10.3389/fneur.2023.1265789. eCollection 2023.
6
REM Behavior Disorder: Implications for PD Therapeutics.REM 行为障碍：对 PD 治疗的启示。
Curr Neurol Neurosci Rep. 2023 Nov;23(11):727-734. doi: 10.1007/s11910-023-01310-1. Epub 2023 Oct 13.
7
Awake or Sleeping? Maybe Both… A Review of Sleep-Related Dissociative States.清醒还是睡眠？或许两者皆是……关于与睡眠相关的分离状态的综述
J Clin Med. 2023 Jun 6;12(12):3876. doi: 10.3390/jcm12123876.
8
Glymphatic System and Mitochondrial Dysfunction as Two Crucial Players in Pathophysiology of Neurodegenerative Disorders.糖酵解系统和线粒体功能障碍作为神经退行性疾病病理生理学中的两个关键因素。
Int J Mol Sci. 2023 Jun 20;24(12):10366. doi: 10.3390/ijms241210366.
9
Parkinson's Disease: A Narrative Review on Potential Molecular Mechanisms of Sleep Disturbances, REM Behavior Disorder, and Melatonin.帕金森病：关于睡眠障碍、快速眼动睡眠行为障碍和褪黑素潜在分子机制的叙述性综述
Brain Sci. 2023 Jun 6;13(6):914. doi: 10.3390/brainsci13060914.
10
Neuroprotective Effect of Melatonin on Sleep Disorders Associated with Parkinson's Disease.褪黑素对帕金森病相关睡眠障碍的神经保护作用。
Antioxidants (Basel). 2023 Feb 6;12(2):396. doi: 10.3390/antiox12020396.
本文引用的文献
1
Factors associated with injury in REM sleep behavior disorder.快速眼动睡眠行为障碍中与损伤相关的因素。
Sleep Med. 2014 Nov;15(11):1332-8. doi: 10.1016/j.sleep.2014.06.002. Epub 2014 Jun 23.
2
Antidepressants and REM sleep behavior disorder: isolated side effect or neurodegenerative signal?抗抑郁药与 REM 睡眠行为障碍：孤立的副作用还是神经退行性信号？
Sleep. 2013 Nov 1;36(11):1579-85. doi: 10.5665/sleep.3102.
3
Use of ramelteon for the treatment of secondary REM sleep behavior disorder.使用雷美替胺治疗继发性快速眼动睡眠行为障碍。
Intern Med. 2013;52(18):2123-6. doi: 10.2169/internalmedicine.52.9179.
4
Rapid eye movement sleep behavior disorder: devising controlled active treatment studies for symptomatic and neuroprotective therapy--a consensus statement from the International Rapid Eye Movement Sleep Behavior Disorder Study Group.快速眼动睡眠行为障碍：制定有症状和神经保护治疗的对照性主动治疗研究——国际快速眼动睡眠行为障碍研究组的共识声明。
Sleep Med. 2013 Aug;14(8):795-806. doi: 10.1016/j.sleep.2013.02.016. Epub 2013 Jul 22.
5
Melatonin in rapid eye movement sleep behavior disorder: why does it work?褪黑素与快速眼动睡眠行为障碍：它为何起作用？
Sleep Med. 2013 Aug;14(8):705-6. doi: 10.1016/j.sleep.2013.05.004. Epub 2013 Jul 17.
6
New aspects in the pathophysiology of rapid eye movement sleep behavior disorder: the potential role of glutamate, gamma-aminobutyric acid, and glycine.快速眼动睡眠行为障碍的病理生理学新方面：谷氨酸、γ-氨基丁酸和甘氨酸的潜在作用。
Sleep Med. 2013 Aug;14(8):714-8. doi: 10.1016/j.sleep.2013.02.004. Epub 2013 Jun 19.
7
Clinicopathologic correlations in 172 cases of rapid eye movement sleep behavior disorder with or without a coexisting neurologic disorder.172 例快速眼动睡眠行为障碍伴或不伴伴发神经障碍的临床病理相关性。
Sleep Med. 2013 Aug;14(8):754-62. doi: 10.1016/j.sleep.2012.10.015. Epub 2013 Mar 7.
8
Treatment outcomes in REM sleep behavior disorder.快速眼动睡眠行为障碍的治疗结果。
Sleep Med. 2013 Mar;14(3):237-42. doi: 10.1016/j.sleep.2012.09.018. Epub 2013 Jan 23.
9
Delayed emergence of a parkinsonian disorder or dementia in 81% of older men initially diagnosed with idiopathic rapid eye movement sleep behavior disorder: a 16-year update on a previously reported series.81%最初被诊断为特发性快速眼动睡眠行为障碍的老年男性在 16 年后出现帕金森病或痴呆：对先前报告系列的更新。
Sleep Med. 2013 Aug;14(8):744-8. doi: 10.1016/j.sleep.2012.10.009. Epub 2013 Jan 22.
10
The parasomnias: mechanisms and treatment.睡眠障碍：发生机制与治疗。
Epilepsia. 2012 Dec;53 Suppl 7:12-9. doi: 10.1111/j.1528-1167.2012.03710.x.
Zotero 插件